179 related articles for article (PubMed ID: 32554061)
21. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
Gao J; Li W; Guo Y; Feng SS
Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
23. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
24. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
25. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells.
Oswald JT; Patel H; Khan D; Jeorje NN; Golzar H; Oswald EL; Tang S
Curr Pharm Des; 2020; 26(17):2057-2071. PubMed ID: 32250211
[TBL] [Abstract][Full Text] [Related]
26. Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies.
Deldar Abad Paskeh M; Asadi S; Zabolian A; Saleki H; Khoshbakht MA; Sabet S; Naghdi MJ; Hashemi M; Hushmandi K; Ashrafizadeh M; Mirzaei S; Zarrabi A; Sethi G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769099
[TBL] [Abstract][Full Text] [Related]
27. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicine-mediated drug targeting of cancer stem cells.
Singh D; Minz AP; Sahoo SK
Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
[TBL] [Abstract][Full Text] [Related]
29. Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms.
Kanwar JR; Samarasinghe RM; Kamalapuram SK; Kanwar RK
Mini Rev Med Chem; 2017; 17(18):1688-1695. PubMed ID: 26891936
[TBL] [Abstract][Full Text] [Related]
30. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.
Subramaniam D; Kaushik G; Dandawate P; Anant S
Curr Med Chem; 2018; 25(22):2585-2594. PubMed ID: 28137215
[TBL] [Abstract][Full Text] [Related]
31. Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells.
Satheesh NJ; Samuel SM; Büsselberg D
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947879
[TBL] [Abstract][Full Text] [Related]
32. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
33. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
34. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells and personalized cancer nanomedicine.
Gener P; Rafael DF; Fernández Y; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S
Nanomedicine (Lond); 2016 Feb; 11(3):307-20. PubMed ID: 26785724
[TBL] [Abstract][Full Text] [Related]
36. Delivering cancer stem cell therapies - a role for nanomedicines?
Schätzlein AG
Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Disease: cancer stem cells--targeting the evil twin.
Trumpp A; Wiestler OD
Nat Clin Pract Oncol; 2008 Jun; 5(6):337-47. PubMed ID: 18431377
[TBL] [Abstract][Full Text] [Related]
38. Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?
Dalpiaz A; Paganetto G; Botti G; Pavan B
Drug Discov Today; 2020 Sep; 25(9):1651-1667. PubMed ID: 32763499
[TBL] [Abstract][Full Text] [Related]
39. HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications.
Bayat S; Shekari Khaniani M; Choupani J; Alivand MR; Mansoori Derakhshan S
Biomed Pharmacother; 2018 Jan; 97():1445-1453. PubMed ID: 29156535
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells in oncology.
Cetin I; Topcul M
J BUON; 2012; 17(4):644-8. PubMed ID: 23335519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
